Interestingly, ACY-1215, when used at HDAC6 selective concentrations (up to 2 μM), did not promote apoptosis; however, if used in combination with other anti-cancer drugs, it proved to be more effective [77,78]. This evidence concerns the gene HDAC6 and cancer.